At the dated check, the references listed below either did not resolve in
Crossref or DataCite, or carried a retraction notice. Each one is shown with the
registry record that put it there.
The 47 checked references that resolve
resolves10.1002/art.1780330203The american college of rheumatology 1990 criteria for the classification of fibromyalgia
resolves10.1038/sj.mp.4001568Erratum: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits
resolves10.1016/S0304-3959(00)00432-2Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome
resolves10.1002/art.1780371106Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome
resolves10.1016/S0304-3959(00)00284-0Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways
resolves10.1016/0028-3908(93)90076-FMonoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices
resolves10.1007/s003930050242Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones
resolves10.1016/S0002-9343(99)00074-1Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome
resolves10.1046/j.1365-2265.2001.01373.xA comparison between low‐dose (1 µg), standard‐dose (250 µg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo–pituitary–adrenal axis in primary fibromyalgia syndrome
resolves10.1080/030097400750001743-1Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients
resolves10.1016/S0306-9877(02)00294-3A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone
resolves10.1159/000026321Differential Effects of Neuropeptides on Cytokine Production by Mouse Helper T Cell Subsets
resolves10.1073/pnas.95.21.12544Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype
resolves10.1002/art.1780370812The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus
resolves10.3109/03009748909095399Fibromyalgia Features in Patients with Primary Sjögren's Syndrome: Evidence of a Relationship with Psychological Depression
resolves10.1007/s00296-007-0413-7Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up
resolves10.1007/s10067-006-0237-yThe frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms
resolves10.1080/08916930701620035Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome
resolves10.1002/art.22026Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain
resolves10.3181/0808-RM-254Plasma Cytokine Fluctuations over Time in Healthy Controls and Patients with Fibromyalgia
The 10 references without a DOI — listed, not checked
no DOI — not checkedFibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM
no DOI — not checkedSerotonin levels, pain threshold, and fibromyalgia symptoms in the general population
no DOI — not checkedAltered reactivity of the hypothalamic‐pituitary‐adrenal axis in the primary fibromyalgia syndrome
no DOI — not checkedDiurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis
no DOI — not checkedAltered reactivity of the hypothalamic‐pituitary‐adrenal axis in the primary fibromyalgia syndrome
no DOI — not checkedSleep disturbances, fibromyalgia and primary Sjögren's syndrome
no DOI — not checkedSevere rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodermographic disadvantage characterize RA patients with fibromyalgia
no DOI — not checkedAntipolymer antibodies in a Danish fibromyalgia patients
no DOI — not checkedCytokine patterns in fibromyalgia and their correlation with clinical manifestations
no DOI — not checkedThe
fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.